| 我国制药企业技术创新 |
| |
| 引用本文： | 屠凤娜,张春河,朱洪瑞. 我国制药企业技术创新[J]. 河北理工大学学报(社会科学版), 2006, 6(1): 84-86 |
| |
| 作者姓名： | 屠凤娜 张春河 朱洪瑞 |
| |
| 作者单位： | 河北理工大学,经济管理学院,河北,唐山,063009 |
| |
| 摘 要： | 技术创新的能力和效率,是制约医药制造企业盈利能力的重要因素.针对我国制药企业因创新能力不足而影响竞争力的现状,提出了要在基础研究、应用研究和产业化等领域技术创新投入、增强企业与科研机构之间的合作、推进医药企业的产权多元化进程等多项对策和建议.
|
| 关 键 词： | 制药企业 技术创新 对策 |
| 文章编号： | 1673-2804(2006)01-0084-03 |
| 修稿时间： | 2005-05-26 |
Pharmaceutical Industry''''s Technical Innovation of Our Country |
| |
| TU Feng-na,ZHANG Chun-he,ZHU Hong-rui. Pharmaceutical Industry''''s Technical Innovation of Our Country[J]. Journal of Hebei Polytechnic University(Social Science Edition), 2006, 6(1): 84-86 |
| |
| Authors: | TU Feng-na ZHANG Chun-he ZHU Hong-rui |
| |
| Abstract: | The ability and efficiency of technical innovation is the most important factor of the pharmaceutical enterprise's profit ability.The present situation of Chinese pharmaceutcal industry's competition is in the lack of innovative ability.In this article,we put forward to countermeasures and suggestions.For example,in the realm of basic research,applied research and industrialization,we should add the input of technical innovation on the basis of present level and should enhance the cooperation between the big enterprise and scientific research institution;we should advance the course of the enterprise's property right multi-industry. |
| |
| Keywords: | pharmaceutical industry technical innovation countermeasures |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
|
